Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Rectal Cancer Survivorship: Impact of Low Anterior Resection Syndrome (LARS) on the Quality of Life

NCT06059170 is registered in ClinicalTrials.gov with University Hospital, Ghent as lead sponsor.

NCT NCT06059170
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06059170 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Rectal Cancer Survivorship: Impact of Low Anterior Resection Syndrome (LARS) on the Quality of Life
Lead sponsor
University Hospital, Ghent
Phase
Not applicable
Overall status
Completed
Start date
March 17, 2017
Completion date
December 31, 2018
Enrollment
187 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

low anterior resection syndrome, rectal cancer